DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
Frequently asked questions
What sector does DRI Healthcare Trust (DHT-U) operate in?
DRI Healthcare Trust belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is DRI Healthcare Trust (DHT-U) current stock price?
As of the latest data, DRI Healthcare Trust stock price is $11.62, with a previous close of $11.62.
What is DRI Healthcare Trust (DHT-U) current market capitalization?
DRI Healthcare Trust market cap is approximately 638.67 million.
What is DRI Healthcare Trust (DHT-U) Earnings Per Share (EPS)?
The trailing EPS is -$0.81, and the forward EPS is -$0.05.
What is DRI Healthcare Trust (DHT-U) EBITDA?
DRI Healthcare Trust EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 34.61 million.
Does DRI Healthcare Trust (DHT-U) pay dividends?
Yes. DRI Healthcare Trust pays quarterly dividends with an annualized yield of 3.79% and an estimated annual payout of $0.44 per share.
When is the next ex-dividend date for DRI Healthcare Trust (DHT-U)?
The next ex-dividend date is scheduled for December 30, 2026.
How did DRI Healthcare Trust (DHT-U) perform in its most recent earnings report?
In the last report (June 30, 2026), DRI Healthcare Trust posted an EPS surprise of 1,000% and a revenue surprise of 5.81%.
When is DRI Healthcare Trust (DHT-U) next earnings report?
DRI Healthcare Trust is expected to release its next earnings report on September 30, 2026.
What is DRI Healthcare Trust (DHT-U) beta (volatility) score?
DRI Healthcare Trust has a beta of 0.620, indicating lower volatility than the overall market.
